2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA
Annual Report to Security Holders
Genelux Corporation Enters $100 Million Sales Agreement with TD Cowen
Investor Presentation
Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
Paul Scigalla Resigns as Chief Medical Officer; Jason Litten Appointed
Material disclosure
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Amended Notice of Proposed Sale of Securities
Correspondence
Submission Upload